The Relationship between Obesity and Skin and Soft Tissue Infections by Swiney, Juliana
University of Kentucky 
UKnowledge 
MPA/MPP Capstone Projects Martin School of Public Policy and Administration 
2010 
The Relationship between Obesity and Skin and Soft Tissue 
Infections 
Juliana Swiney 
University of Kentucky 
Follow this and additional works at: https://uknowledge.uky.edu/mpampp_etds 
 Part of the Health and Medical Administration Commons, Health Policy Commons, and the Skin and 
Connective Tissue Diseases Commons 
Right click to open a feedback form in a new tab to let us know how this document benefits you. 
Recommended Citation 
Swiney, Juliana, "The Relationship between Obesity and Skin and Soft Tissue Infections" (2010). MPA/
MPP Capstone Projects. 140. 
https://uknowledge.uky.edu/mpampp_etds/140 
This Graduate Capstone Project is brought to you for free and open access by the Martin School of Public Policy 
and Administration at UKnowledge. It has been accepted for inclusion in MPA/MPP Capstone Projects by an 
authorized administrator of UKnowledge. For more information, please contact UKnowledge@lsv.uky.edu. 
UNIVERSITY OF KENTUCKY: THE MARTIN SCHOOL OF PUBLIC POLICY AND ADMINISTRATION 
The Relationship Between Obesity and Skin and Soft Tissue Infections Capstone Project 2010 
 
Juliana Swiney MSPT, PharmD/MPA Candidate 2010 
4/22/2010 
 
  
 2 
 
 
Table of Contents 
 
I.     Executive Summary ............................................................................................................. 3 
II.     The Problem Statement ...................................................................................................... 4 
III. Background ......................................................................................................................... 6 
IV. Research Strategy and Methods ........................................................................................ 9 
The Sample .................................................................................................................................. 9 
Measures ................................................................................................................................... 10 
Procedures/ Statistical Tests ..................................................................................................... 12 
V.     Results ............................................................................................................................. 138 
VI. Discussion .......................................................................................................................... 24 
VII. Limitations ........................................................................................................................ 25 
VIII. Recommendations for Future Studies ............................................................................. 26 
Appendix I: Tables ......................................................................................................................... 29 
Bibliography ................................................................................................................................... 30 
   
 
 3 
I. Executive Summary 
The Problem: 
 It is well known that our country is experiencing an obesity epidemic: 33.9% of 
all adults are obese (BMI>30) and 67% of adults are either overweight or obese 
(BMI>25). Obesity is a risk factor for several serious disease states such as, diabetes, 
stroke, hypertension, heart disease and some types of cancer.  It also has a less well 
defined relationship with skin and soft tissue infections.   
Although it is known that excessive weight increases the opportunity for harmful 
skin conditions, this relationship has not been as well studied. Some of the mechanisms 
that predispose obese people to infections are known, but much of the interrelationship 
remains uncertain especially its impact on health care cost and policy.  This study 
contributes to the limited knowledge on the relationship between obesity and skin and 
soft tissue infections. 
Research Strategy and Methods: 
Using the H-CUP national data base for inpatient hospitalizations, this study 
analyzed the data from the hospitals in several states in the South for the number of 
skin and soft tissue infections for the years 2003, 2005, 2007.  Using the co-morbidity 
code for obesity, the proportion of patients who are also obese in this population was 
quantified for each of the three years specified.  Two linear regressions analyzed the 
impact of obesity on the cost of health care by using length of stay and total hospital 
charges as dependent variables. 
Major Findings: 
 The proportion of patients hospitalized for skin and soft tissue infections that are 
also obese has increased from 47.56% in 2003 to 50.42% in 2007.  Surprisingly, the co-
morbidity of obesity has a negative predictive value for both hospital length of stay and 
total hospital charges. 
Recommendations for Further Studies:  
 This study is an initial evaluation of the relationship between obesity and skin 
and soft tissue infections.  More research is needed to determine whether obesity is a 
causal factor in skin and soft tissue infections and how this is affecting the cost and 
delivery of health care.  Local, state and federal governments are beginning to create 
policies aimed at addressing the obesity epidemic, but the research to support such 
policies is in its infancy and requires more attention to be able to inform the policy 
process adequately. 
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II. The Problem Statement 
It is well known that obesity can lead to other chronic disease states including 
hypertension, type 2 diabetes, coronary heart disease, some cancers, hyperlipidemia 
and osteoarthritis.1,2,3,4  Obesity is also known to be directly related to an increased risk 
of gallbladder disease, stroke, infertility, sleep apnea and musculoskeletal disease.5,6,7,8,9  
A 2008 study found that overweight and obese people were 16% more likely to 
have dyslipideamia, 7% more likely to have heart disease, 14% more likely to have 
hypertension, and 5% more likely to have sleep apnea.3 The obese individual has a 3.85 
times greater risk of hospitalization than the non-obese person.10  Thompson found that 
the risk of hypertension is about 2-fold higher and the risk for type 2 diabetes is almost 
3 fold higher in the obese person.11 Also, nearly 60% of type 2 diabetes is attributable to 
obesity.12 These co-morbidities contribute to the cost and also to the mortality and 
morbidity of those who are overweight and obese.  
The connection of obesity with skin and soft tissue disease is less well studied 
than with other disease states.  Wolf found from the PROCEED study that people who 
are overweight or obese have an 8% greater prevalence of self-reported skin condition 
symptoms than the person who has normal weight.3   Unfortunately, the types of skin 
conditions were not defined in that study.  
Some of the mechanisms that predispose obese people to infections are known, 
but much of the interrelationship remains uncertain especially its impact on health care 
cost and policy.  This study attempts to illuminate one small piece of this puzzle. 
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Using the H-CUP national data base for inpatient hospitalizations, I analyzed the 
data from the hospitals in several states in the South for the number of skin and soft 
tissue infections for the years 2003, 2005, 2007.  Using the co-morbidity code for 
obesity, I also found the proportion of patients who are also obese in this population 
and track the trends for the three years specified.  My hypothesis is that within the 
population of patients who are admitted for skin and soft tissue infections, the 
proportion of those who are also obese is increasing.   
I have chosen to confine the research to hospitals in the South since this 
information is more relevant to the state of Kentucky and also because the South’s rate 
of obesity is rising more quickly than other regions of the United States.34 As such, if the 
rate of obesity within this population is increasing, this is the region in which it will most 
likely be found.  The hospitals in the sample are a mix of large and mid-size hospitals so 
as to capture urban and more rural areas of the states.   
A secondary outcome is the cost of obesity related skin and soft tissue infections 
using total hospital charges (Total Charges) and length of stay (LOS) as proxies for cost.  
A regression analysis was completed using length of stay and another using Total 
Charges as the dependent variables and age, gender of patient, median household 
income quartiles for patient’s ZIP code, payer information, race and co-morbidity codes 
as independent variables.   
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III. Background  
According to the CDC, the percent of obese adults in America (BMI>30) in 2006 
was 33.9% and the percent of adults overweight (including obese) with a BMI>25 was 
67%.  Since the 1980-s each decade has brought an increasing prevalence of overweight 
and obese adults.12,13  The latest research indicates that the prevalence of obesity seems 
to be stabilizing at 33.8% overall among adults and the prevalence estimates for 
overweight and obesity combined has stabilized at 68%.14  
Encouragingly, the prevalence of a BMI for age at or above the 95th percentile 
(what is considered “obese” in children) among children and adolescents has also 
showed no significant changes between 1999 and 2006 except among the very heaviest 
3-19 year old boys.  However, it remains high at approximately 17%.15   
This health issue touches all ethnic groups in all the states of the union and is 
spreading to other industrialized nations as well.12,16  It is truly an epidemic which 
demands the attention of health care policy not only for its impact on individual health 
but also for its economic impact on the health care system.17   
Unfortunately for Kentucky, the South is leading the country in these trends.  As 
such, the importance of understanding the impact of obesity carries even greater 
significance and urgency.  The cost of obesity and disease states induced by obesity is 
truly staggering.  Currently, the cost of obesity for the country is about $147 billion and 
it now accounts for about 9.1% of medical spending.  In Kentucky alone, the estimated 
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direct health care costs associated with obesity in 2008 were $1.2 billion.35   According 
to Wolf the mean health care costs of a person with a BMI of 20-24 (considered normal 
weight) was $456 ± 937 compared to a person with a BMI of >30 which was $1186 ± 
2808.3   Another study found that overall health care costs for overweight and obese 
people were 37% higher than for people with normal weight.18   
In 2001, the obesity-attributable costs of health insurance to US businesses were 
estimated to account for 4.6% of total business spending on employee health 
insurance.1  Also, it was found that mean annual medical-care costs were 36% higher 
over nine years for people who were obese compared to people with normal BMIs.1 The 
combination of the two major determinants of obesity, lack of physical activity and 
excess caloric intake is now second only to smoking as the leading preventable cause of 
death in the United States.19,20  Obesity is now responsible for more health care 
expenditures, including direct and indirect costs, than any other contributory health 
condition including smoking and problematic drinking.19,20 
  There are several mechanisms by which obesity increases the opportunity for 
harmful skin conditions. Excessive fat folds favor humidity and maceration (the 
breakdown of skin that is constantly kept wet) with bacterial and fungal overgrowth 
which can lead to severe infections requiring hospitalization for treatment.  The 
pressure within skin folds can be sufficient in and of itself to cause skin breakdown and 
secondary infection.21,22  
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Obesity also impedes lymphatic flow, thus the accumulated protein-rich 
lymphatic fluid decreases oxygenation of the surrounding tissue leading to fibrosis and a 
chronic inflammatory state.5   This state provides a hospitable culture medium for 
bacterial growth which can lead to serious infection.  The pH of the skin is also higher in 
people who are obese which is more conducive for candidal superinfections since 
Candida thrives in alkaline environments.5   
Obesity is also a risk factor for the development of chronic venous insufficiency 
which is a risk factor for venous ulcerations.22   And since obesity decreases wound 
healing by diminishing perfusion to the injured tissue, these ulcers tend to be more 
severe and more difficult to treat.  Increased tension on the wound edges from obesity 
may further aggravate wound healing or lead to dehiscence (reopening of a closed 
wound).22,23 
In addition, obesity increases the incidence of several other more serious skin 
conditions: erysipelas (an acute streptococcal skin infection), intertrigo (inflammation of 
the skin folds), cellulitis (diffuse inflammation of connective tissue in the dermal and 
subcutaneous layers), and necrotizing fasciitis (a rapidly spreading infection of the fascia 
in the subcutaneous tissue due to toxins released by bacteria).22,24,25  One study 
revealed that 88% of women hospitalized for necrotizing fasciitis were obese.26     
This relationship between skin and soft tissue infections and obesity has not 
garnered as much attention as other disease states related to obesity, but the current 
research demonstrates that there is a relationship between the two.  As the economic 
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burden of obesity continues to have a significant impact on health care, this relationship 
may prove to be a significant portion of the overall cost.  This study is a preliminary 
foray into the health care cost of obesity and skin and soft tissue infections. 
  
IV. Research Strategy and Methods  
The Sample 
 The data used for this project came from the Healthcare Cost and Utilization 
Project (H-CUP) Nationwide Inpatient Sample (NIS) for the years 2003, 2005, 2007.  The 
year 2001 was originally to be used so as to give a greater spread of time to capture 
more data for the proposed hypotheses; however, the 2001 data set did not include the 
co-morbidity codes from the Disease Severity Measure files that were present in the 
other years.  As such, I would not be able to compare the data from 2003-2007 with 
2001, so this data set was not used in the analysis.   
The NIS is a database of hospital inpatient stays that includes charge information 
on all patients regardless of payer and also includes clinical and resource use 
information typically available from discharge abstracts.  Each year of the NIS provides 
information on approximately 5 million to 8 million inpatient stays from about 1,000 
hospitals nationwide.  The NIS is designed to approximate a 20-percent sample of U.S. 
community hospitals (this includes specialty hospitals, public hospitals, private hospitals, 
academic medical centers, acute care hospitals, but not short-term rehabilitation 
hospitals, long-term non-acute care hospitals, psychiatric hospitals and 
alcoholism/chemical dependency treatment facilities).   
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 For this study, only the data from the following states were used: Kentucky, 
Georgia, North Carolina, South Carolina, Tennessee and West Virginia.  These states 
were chosen because data for them is present in all three years and they are in the 
Southern region of the country. Mississippi, Alabama and Louisiana are not in the NIS 
database, Virginia’s data for 2005 was not available and Arkansas’ data for 2003 was not 
available.  While Florida and Texas have data available for all three years, the population 
in each of these states is substantially different than the general population of Kentucky. 
The data for this research were chosen by selecting admission diagnosis ICD-9 
codes (International Statistical Classification of Diseases and Related Health Problems 
9th Revision) that indicated that the admission was due to a skin or soft tissue infection 
for the states listed above. The following ICD-9 codes were used: 707 (chronic ulcer of 
skin), 680-686 (infections of skin and subcutaneous tissue) and 728.86 (necrotizing 
fasciitis).   
Measures 
The following data elements were selected for each record: age, diagnosis ICD-9 
code, whether the patient died in the hospital, gender of patient, HCUP hospital 
number, state postal code for the hospital, length of stay (LOS), median household 
income quartiles for patient’s ZIP code, primary payer information, race, key record 
identifier and total hospital charges (Total Charges).   
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Table 1: Data elements from H-CUP Nationwide Inpatient Sample 
Age Age in years coded 0-124 years 
Female Dummy Variable.  Indicates gender 0=male, 1=female 
LOS Length of stay in number of days 
Died Dummy Variable.  Indicates in-hospital heath: 0=did not die 
during hospitalization, 1=died during hospitalization 
ZipQrtl Median household income quartiles for patient’s ZIP code. 
1=$1-$38,999 2=$39,000-$47,999 3=$48,000-$62,999 
4=$63,000 or more 
PAY Expected primary payer 1=Medicare, 2=Medicaid, 3=private 
including HMO, 4=self-pay, 5=not charge 
RACE Race, uniform coding 1=white, 2=black, 3=Hispanic, 4=Asian or 
pacific islander, 5= native American, 6=other 
HOSPST State postal code for the hospital (e.g. AZ for Arizona) 
Cm_Arth AHRQ co-morbidity measure: Rheumatoid arthritis/collagen 
vascular diseases: 0=co-morbidity is not present 1-co-
morbidity is present 
Cm_DM AHRQ co-morbidity measure: diabetes uncomplicated:  0=co-
morbidity is not present 1-co-morbidity 
Cm_Dmcx AHRQ co-morbidity measure: diabetes with chronic 
complications: 0=co-morbidity is not present 1-co-morbidity 
Cm_HTN_c AHRQ co-morbidity measure Hypertension (combine 
uncomplicated and complicated):  0=co-morbidity is not 
present 1-co-morbidity 
Cm_Obese AHRQ co-morbidity measure: Obesity: 0=co-morbidity is not 
present 1-co-morbidity 
 
This selected data from the core files was then matched with data from the 
Disease Severity Measure files for the following co-morbidity data elements: 
rheumatoid arthritis/collagen vascular disease, diabetes, diabetes with chronic 
complications, hypertension, and obesity.  These co-morbidity data elements were 
chosen because of their established relationship with obesity.  The program used to 
analyze the data was STATA 11. 
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Procedures/ Statistical Tests 
 The percentage of admissions for a diagnosis of skin and soft tissue infection that 
were also coded as having the co-morbidity of obesity was calculated for each of the 
three years and a Chi- Square ( χ² ) test was completed to determine if a statistically 
significant difference existed among the three years.   
Two linear regressions were conducted with Length of Stay and Total Charges as 
the dependent variables.   A multi-collinearity check was done in order to make sure 
there was no significant association or correlation among the variables for each 
regression.  Several iterations of the regression were run in order to find the significant 
variables that explained each of the dependent variables, LOS and Total Charges.  
The first LOS model was expressed as:   
LOS= f(ageβ
1 
+ femaleβ
2 
+ Medicareβ
3 
+ Medicaidβ
4 
+ PrivatePayβ
5 
+ SelfPayβ
6 
+ 
NoChargeβ
7 
+ Whiteβ
8 
+ Blackβ
9 
+ Hispanicβ
10 
+ AsianorPacificβ
11 
+ NativeAmericanβ
12 
+ 
ZipQrtl1β
13 
+ ZipQrtl2β
14 
+ ZipQrtl3β
15 
+ ZipQrtl3β
16 
+ ZipQrtl4β
17 
+ cm_arthβ
18 
+ 
cm_dmcxβ
19 
+ cm_htn_cβ
20 
+ cm_obeseβ
21 
+ β
0
 +ε)  
The final LOS model used for explanation of the relevant results was expressed as:  
LOS= f(ageβ
1 
+ femaleβ
2 
+ Medicareβ
3 
+ Medicaidβ
4 
+ Blackβ
9 
+ ZipQrtl1β
13 
+ ZipQrtl4β
17 
 
+ cm_dmcxβ
19 
+ cm_htn_cβ
20 
+ cm_obeseβ
21  
+β
0
+ ε)  
A similar first model was expressed for Total Charges as the dependent variable: 
Total Charges= f(ageβ
1 
+ femaleβ
2 
+ Medicareβ
3 
+ Medicaidβ
4 
+ PrivatePayβ
5 
+ SelfPayβ
6 
+ NoChargeβ
7 
+ Whiteβ
8 
+ Blackβ
9 
+ Hispanicβ
10 
+ AsianorPacificβ
11 
+ NativeAmericanβ
12 
+ ZipQrtl1β
13 
+ ZipQrtl2β
14 
+ ZipQrtl3β
15 
+ ZipQrtl3β
16 
+ ZipQrtl4β
17 
+ cm_arthβ
18 
+ 
cm_dmcxβ
19 
+ cm_htn_cβ
20 
+ cm_obeseβ
21 
+ β
0
 +ε)  
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The final Total Charges model used for explanation of the relevant results was expressed 
as: 
Total Charges =f(ageβ
1 
+ femaleβ
2 
+ Medicareβ
3 
+ Medicaidβ
4 
+ PrivatePayβ
5 
+ SelfPayβ
6  
+ Whiteβ
8 
+ Blackβ
9 
+ ZipQrtl1β
13 
+ ZipQrtl4β
17 
+ 
 
+ cm_dmcxβ
19 
+ cm_htn_cβ
20 
+ 
cm_obeseβ
21 
+ β
0
 +ε)  
 
Since LOS and Total Charges do not have a normal distribution, a linear 
regression is not the most accurate model to use.  A more accurate model would use 
the log of the dependent variable in order to compensate for the skewed data.  
However, some of the data points for LOS were 0 and therefore, a log-transformation of 
the dependent variable was not possible.  
 
V. Results 
Characteristics of the sample used for this research are presented in Table 2.  
Each observation is one hospital admission.  The number of observations for patients 
admitted to hospitals with skin and soft tissue infections is over 100,000 for each of the 
three years, thus providing a large sample size for this research project.  
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Table 2: Descriptive statistics for each of the three years of data (2003, 2005, 2007) 
 2003 2005 2007 
# of Observations 103,987 118,724 117,292 
Avg. Length of Stay (days) 6.2 6.19 6.29 
Avg. Total Charges (dollars) $19,774 $23,715 $26,501 
Avg. Age (years) 56.58  54.51 54.31 
Male (%) 42,517 
(40.89%) 
48,707 
(41.03%) 
48,190 
(41.06%) 
Female (%) 61,466 
(59.11%) 
70,013 
(58.97%) 
69,134 
(58.94%) 
Medicare (%) 50,536 
(48.77%) 
54,924 
(46.42%) 
53,190 
(45.76%) 
Medicaid (%) 14,394 
(13.89%) 
18,839 
(15.92%) 
17,846 
(15.35%) 
Private Pay/HMO (%) 29,372 
(28.25%) 
32,172 
(27.1%) 
32,093 
(27.36%) 
Self Pay (%) 5,127  
(4.93%) 
7,978  
(6.72%) 
8,497 
(7.24%) 
White (%) 37,865 
(71.05%) 
35,477 
(73.78%) 
30,782 
(70.03%) 
Black (%) 14,244 
(26.73%) 
11,815 
(24.57%) 
11,800 
(26.84%) 
Lower Income  
Zip Qrtl 1 (%) 
41,064 
(40.83%) 
49,746 
(43.30%) 
54,706 
(48.19%) 
Higher Income 
Zip Qrtl 4 (%) 
8,611  
(8.56%) 
8,595 
 (7.48%) 
9,783 
(8.62%) 
Co-Morbidity: Diabetes uncomplicated 
(%) 
27,712 
(26.65%) 
30,141 
(25.39%) 
31,688 
(27.02%) 
Co-Morbidity: Diabetes with chronic 
complications (%) 
7,655  
(7.36%) 
8,449  
(7.12%) 
8,908 
(7.59%) 
Co-Morbidity: Hypertension (%) 49,754 
(47.85%) 
57,284 
(48.25%) 
59,199 
(50.47%) 
Co-Morbidity: Obesity (%) 49,459 
(47.56%) 
55,617 
(46.85%) 
59,139 
(50.42%) 
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The percent of admissions for skin and soft tissue infection that were also coded 
for obesity decreased for the year 2005 (46.85%) from the year 2003 (47.56%), but 
increases for the year 2007 (50.42%).  The overall percentage of patients coded for the 
co-morbidity of obesity for all three years was 48.3%. 
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A Chi- Square ( χ² ) test was performed to test the null hypothesis that there 
were no differences among the three years proportions of admissions that were coded 
as having a co-morbidity of obesity. The results from STATA are presented in Table 3. 
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Table 3: Chi-Squared Analysis for the proportion of people hospitalized with skin and 
soft tissue infections that were also coded as obese (0=not obese, 1=obese) for each 
year (2003, 2005, and 2007) 
 
 
Since the computed test statistic (χ² =334.3763) is greater than the critical value 
(5.991) the null hypothesis is rejected.  As such, it can be concluded that there is a 
statistically significant difference in the proportion of patients admitted with a co-
morbidity of obesity for the three years in the data set.   
A linear regression using all three years of data (2003, 2005, 2007) was used to 
predict Length of Stay (dependent variable).  All variables that were not statistically 
significant were dropped and resulted in the following equation:  
 
 
          Pearson chi2(2) = 334.3763   Pr = 0.000
                  22.5      100.3      211.5       334.4 
     Total     103,987    118,724    117,292     340,003 
                                                        
                  11.6       51.9      109.4       172.9 
         1      49,459     55,617     59,139     164,215 
                                                        
                  10.9       48.4      102.2       161.5 
         0      54,528     63,107     58,153     175,788 
                                                        
  cm_obese        2003       2005       2007       Total
                           YEAR
                     
  chi2 contribution  
      frequency      
                     
  Key                
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 LOS= f( 0.0342age
 
 - 0.4245female
 
+ 1.103Medicare
 
+ 1.381Medicaid
 
+ 1.257Black
 
 -
0.1657ZipQrtl1+ .104ZipQrtl4
 
 + 0 .884cm_dmcx
  
- 0.835 cm_htn_c
 
 - 2.65cm_obese
  
+5.419+ ε)  
 
Refer to Table 4 for the regression analysis using length of stay as the dependent 
variable. 
 
Table 4: Linear Regression Analysis for Length of Stay as the Dependent Variable 
 
 
Independent 
Variable 
Coefficient Standard 
Error 
t-value P>|t| 95% confidence 
interval 
Age 0.034 0.0008 38.43 0.000 (0.032, 0.036) 
Female -0.424 0.0273 -15.52 0.000 (-0.478, -0.37) 
Medicare 1.103 0.0352 31.31 0.000 (1.034, 1.172) 
Medicaid 1.381 0.0413 33.39 0.000 (1.3, 1.462) 
Black 1.257 0.0432 29.72 0.000 (1.174,  1.34) 
Lower income 
level (ZipQrtl1) -0.165 0.0277 -5.97 0.000 (-0.2201, -0.1113) 
Higher income 
level (ZipQrtl4) 0.104 0.051 2.07 0.038 (0.0055, 0.2041) 
Diabetes 
comorbidity 
0.884 0.051 17.3 0.000 (0.784, 0.984) 
Hypertension 
comorbidity 
-0.835 0.028 -29.83 0.000 (-0.89, -0.78) 
Obesity 
comorbidity 
-2.654 0.027 -94.91 0.000 (-2.709, -2.599) 
Constant 5.419 0.051 106.09 0.000 (5.319, 5.519) 
Number of Observations 339,968 
F(10,339957) 2180.08 
Prob > F 0.000 
R-squared 0.0603 
Adjusted R-squared 0.0602 
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In this regression model four variables (gender, lower income (zipQrtl1), co-
morbidities of hypertension and obesity) predict a decrease in the length of stay while 
six variables (Age, Medicare, Medicaid, Black, higher income (ZipQrtl4) and co-morbidity 
of diabetes with complications) predict an increase the length of stay.  The r-squared for 
this regression is 0.0603. This indicates that 6.03% of the variation in length of stay is 
explained by this set of independent variables.  This seems low, but given the 
complexity of hospital length of stay and the simplicity of this model, it is acceptable. 
A linear regression using all three years of data was used to predict Total Charges 
(dependent variable) and resulted in the following equation: 
Total Charges =f ( 94age  - 3087female  - 1101Medicare  - 845Medicaid  - 649PrivatePay  
- 5355SelfPay
  
+ 1474 White
 
+ 4521Black - 2220ZipQrtl1
 
+ 1995ZipQrtl4
 
+ 1347cm_dmcx 
 
- 
935 cm_htn_c
 
 - 4298 cm_obese
 
+ 23472 +ε)  
 
Refer to Table 5 for the regression analysis using Total Charges as the dependent 
variable. 
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Table 5: Linear Regression Analysis for Total Charges as the Dependent Variable 
  
More of the data elements were statistically significant independent variables in 
the regression for Total Charges than in the regression analysis for Length of Stay. 
Overall,  eight variables have a negative predictive value for total charges (gender, 
Medicare, Medicaid, Private Pay/HMO, Self Pay, lower income (ZipQrtl1), co-morbidities 
of hypertension and obesity) and five variables have a positive predictive value for total 
charges (age, white, black, higher income (ZipQrtl4) and co-morbidity of diabetes with 
Independent 
Variable 
Coefficient Standard 
Error 
t-value P>|t| 95% confidence 
interval 
Age 94.70 4.111 23.04 0.000 (86.64, 102.76) 
Female -3087.30 125.989 -24.50 0.000 (-3334.2, -2840.36) 
Medicare -1101.44 315.492 -3.49 0.000 (-1719.8, -483.09) 
Medicaid -845.52 331.933 -2.55 0.011 (-1496.1, -194.94) 
Private 
Pay/HMO 
-649.86 311.960 -2.08 0.037 (-1261.2, -38.43) 
Self Pay -5355.96 377.717 -14.18 0.000 (-6096.2, -4615.64) 
White 1474.99 136.590 10.80  (1207.2, 1742.7) 
Black 4521.03 200.710 22.53 0.000 (4127.6, 4914.4) 
Lower income 
level (ZipQrtl1) -2220.18 128.107 -17.33 0.000 (2471.2, -1969.1) 
Higher income 
level (ZipQrtl4) 1995.34 232.616 8.558 0.000 (1539.4, 1461.2) 
Diabetes 
comorbidity 
1347.91 235.417 5.73 0.000 (886.4, 1809.3) 
Hypertension 
comorbidity 
-935.69 128.840 -7.26 0.000 (-1188.2, -683.17) 
Obesity 
comorbidity 
-4298.25 128.778 -33.38 0.000 (-4550.6, -4045.8) 
Constant 23472.34 360.869 65.04 0.000 (22765, 24179.6) 
Number of Observations 334,998 
F( 13,334984) 363.27 
Prob > F 0.000 
R-squared 0.0139 
Adjusted R-squared 0.0139 
 21 
complications).  All of the payer sources decrease the predicted value of total charges to 
varying degrees while the subcategories of race (white, black) both increase the 
predicted value for total charges.  The r-squared for this regression model is 0.0139 
indicating that 1.39% of the variation in total hospital charges is explained by the 
independent variables in this regression analysis.  As in the Length of Stay regression, 
this r-squared value is low but not unexpected. 
The regression analysis revealed some very interesting results for Length of Stay 
and for Total Charges.  Most surprising is the finding that obesity has a negative 
predictive value for Length of Stay and for Total hospital Charges which seems 
counterintuitive.  The hypothesis was that a co-morbidity of obesity would increase 
Length of Stay and Total Charges due to the added complications and poorer healing of 
skin and soft tissue infections in this population. However, neither regression model 
supports that hypothesis. For the Length of Stay regression with all other variables held 
constant, a co-morbidity of obesity decreases the LOS by 2.65 days.  This is a statistically 
significant decrease with a p-value of less than 0.001.  Given that the average Length of 
Stay is about 6.2 days a decrease of 2.65 days will definitely have an impact on hospital 
costs.  This is seen in the Total Charges regression that with all other variables held 
constant, the co-morbidity of obesity decreases total hospital charges by $4,292. 
Not surprisingly, increasing age will increase length of stay, most probably due to 
older people having more advanced disease states requiring more complicated 
treatments.  Holding all other variables constant, every 1 year of age adds 0.03 days to 
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length of stay and $94 to total hospital charges. Being a women decreases length of stay 
by almost a half a day (.424 days) and it also reduces the total hospital charges by 
$3,087. 
Living in ZipQrt 1 (a proxy for lower income level) decreases length of stay by 
.165 days.  This is due to the effect of income independent of Medicaid.  If these people 
do not have Medicaid, then they stay in the hospital for a shorter period of time. But, if 
they have Medicaid (an income based health insurance) as the payer source, then the 
length of stay increases by 1.38 days.  Living in a more affluent community as indicated 
by ZipQrt4 predicts an increase in total charges by $1,995 and an increase in length of 
stay by 0.104 days.  
Race also impacts the length of stay.  Being Caucasian does not have a 
statistically significant impact on the Length of Stay regression where as being black 
increases length of stay by one and a quarter days.   However, for Total Charges, being 
Caucasian is statistically significant and predicts an increase in total charges by $1,474 
while being Black increases total charges by $4,521 per hospital admission.    
The only co-morbidity that has a positive predictive value in Length of Stay and 
Total Charges is diabetes (with chronic complications). For each regression the p-value is 
less than 0.001 for this co-morbidity. And while having chronic complications for 
diabetes will increase length of stay by almost a day, having hypertension decreases 
length of stay by almost the same amount.  Both of the co-morbidities for hypertension 
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and obesity have a negative predictive value for length of stay and total hospital 
charges. 
Another difference between the two regressions is the payer source.  While 
private pay/HMO and self pay were not statistically significant for Length of Stay they 
were both statistically significant for Total Charges (p-value 0.037 and <0.000 
respectively).  
There is some agreement between these two regression analyses as to what 
decreases length of stay and also decreases total hospital charges: female gender, lower 
income and co-morbidities of hypertension and obesity.  Age, black race, higher income, 
and co-morbidity of diabetes with complications all increase length of stay and total 
hospital charges.   
However, other variables predict opposing directions in the two models.  For 
example, Medicare and Medicaid both increase length of stay but also, both decrease 
total charges.  In fact, all of the payer sources decrease the predicted total charges.  This 
can be explained by noting that the y-intercept for the Total Charges regression is 
$23,472.  If you consider that among the payer sources, Medicaid subtracts less than 
Medicare from this value (-$845 vs. -$1,101), then it is reasonable to think that it 
subtracts less because the patients are in the hospital longer.  This is supported by the 
Length of Stay regression where Medicaid predicts an increase in length of stay by 1.38 
days vs. 1.1 days for Medicare.  
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VI. Discussion 
The percentage of people admitted to the hospital for a skin and soft tissue 
infection that also have a co-morbidity of obesity changed for the three years of data.  
In 2003, the percentage was 47.56% and this dropped slightly to 46.85% in 2005 but 
then rose to 50.42% in 2007.  As the χ² test indicates, this is a statistically significant 
difference in the proportions.  So, while the obesity prevalence has not measurably 
increased in the past few years nationally, the obesity prevalence in patients admitted 
with skin and soft tissue infections has increased for this population.  This would seem 
to indicate that obesity is continuing to play a greater role in patients who have skin and 
soft tissue infections that require admission to hospitals.  And, given that about 50% of 
these patients are coded as having a co-morbidity of obesity, this could be an important 
relationship to investigate in future research. 
The percentage of people who are obese in this population is greater than the 
national average for each of the three years and is also greater than individual state 
averages of 29.8% in KY, in 29.0% NC, 30.1% in SC, 30.6% in TN, 31.2% in WV for the 
year 2008.12 This data suggests that among people with skin and soft tissue infections a 
greater percentage of them are also obese as compared to the general population. This 
may indicate that obesity increases the chance that a person may require hospitalization 
for a skin and soft tissue infection but a definitive answer to that question is beyond the 
scope of this research project.  Further research into the causal relationship between 
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obesity and skin and soft tissue infections would be able to address that question more 
fully. 
Table 6: Percent of people hospitalized with skin and soft tissue infections that are also 
obese for each state for all three years of data combined (2003, 2005 and 2007) 
   State    
Co-Morbidity of Obese GA KY NC SC TN WV 
No 41,501 23,694 45,580 16,324 33,771 14,918 
Yes 41,748 22,237 44,508 15,838 27,402 12,482 
Percent Obese in each state 50.14% 48.41% 49.4% 49.2% 44.79% 45.55% 
 
VII. Limitations 
 There are several limitations of this research project.  Each regression analysis 
used a simple linear regression which is not the most appropriate regression to use 
since Length of Stay and Total Charges do not have a normal distribution.  A more 
accurate model would use a log-transformation of the dependent variable.  Also, only a 
few variables (age, gender, payer source, race, a proxy for income level and co-
morbidities) were used as independent variables.  There are many more variables that 
are involved in length of stay and in the total hospital charges that are not reflected in 
this data analysis.   
The ICD-9 codes that were used for skin and soft tissue infections cover a broad 
range of types and severity of infection.  For example, the ICD-9 code 682 is for “other 
cellulitis and abscess” and can be further specified by location but nothing in the code 
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suggests the causal organism of the cellulitis or the severity of the infection or whether 
or not the patient has an abscess or has cellulitis.   
Also, the proxy used for a patient’s income level in this data is the median 
household income quartiles for the patient’s zip code which introduces some 
inaccuracies since it is grouping the income level for the patients by the geographic area 
of the zip code and assigning the median income level for that whole group.   
Another limitation is that this research project only used data from three years 
that covers a range of five years from 2003 to 2007.  This may not be enough time to 
capture the subtleties of the changes in obesity prevalence in this population.   
Lastly, the information in this data set depends on the voluntary reporting by 
hospitals and the ICD-9 codes are taken from patient discharge abstracts.  This 
introduces the possibility of inconsistent reporting and coding differences by different 
hospitals which may have affected the results of the analysis.    
 
VIII. Recommendations for Future Studies 
This project has been an opportunity to delve into the complex relationship 
between obesity and skin and soft tissue infections, but it has only just begun to tease 
out some of the information imbued in this data set.  The societal impact of obesity in 
relation to other disease states like diabetes or hypertension has received more 
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research attention, but this relationship is an area ripe with research possibilities as 
well.  This study has identified some interesting questions for future research.  For 
example:  are the types of infections that people who obese are admitted for different 
or more severe than the types of infections for which non-obese people are admitted?  
Is there a difference in the proportion of people admitted for skin and soft tissue 
infection who are also obese in different regions of the country? Further research into 
obesity and skin and soft tissue infections would be advised due to the health, economic 
and policy implications in our general population.  As our nation struggles with the cost 
of healthcare and the best way in which to deliver the care, the policy implications 
involved in obesity are riveting.  
It seems that the current laws and policies aimed at preventing or reducing 
obesity may be having a positive impact given that the latest data from NHANES 
concludes that obesity rates have leveled off nationally.  I think that it is important for 
our society to consider how involved our government should be in our individual health 
choices.  Since obesity is predominantly a result of greater calories consumed than 
expended, and eating is a necessary function for life (unlike tobacco or alcohol), how 
does a government try to improve the individual choices a person makes about what to 
eat for lunch?   
In 2007, the National Cancer Institute (NCI) convened a meeting to discuss 
priorities for a research agenda to inform obesity policy and in 2009 this group issued a 
“call to action” to the research community to investigate public policy to effect 
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structural change in order to alter population-level diet and physical activity 
behavior.27,28   
There is already some public policy legislation focused on the obesity issue at the 
federal, state and local levels of government. The Food, Conservation and Energy Act of 
2008 provides $1.3 billion in new funding over ten years for growing fruits, vegetables 
and nuts.  It also provides vouchers for low-income seniors to purchase fruits and 
vegetables from local farmers and it provides about $500 million for states to provide a 
fresh fruit or vegetable snack in schools.29  Kentucky enacted legislation that limits the 
beverages available in schools to water, 100% juice drinks, low-fat milk and beverages 
with no more than ten grams of sugar per serving.30  Indiana passed a statute requiring 
daily physical activity in all elementary schools.31  And, New York City’s Department of 
Health and Mental Hygiene implemented a rule mandating that day care services offer 
at least sixty minutes of activity and limiting video viewing to educational programs. 32 
The most recent federal legislation, Patient Protection and Affordable Care Act, 
requires calorie and content be displayed next to the menu items in fast-food and chain 
restaurants.  It also includes the formation of a National Prevention, Health Promotion 
and Public Health Council that has the mandate to provide recommendations to the 
President and Congress about changes in federal policy regarding sedentary behavior.33  
As such, the more that is known about the impact of obesity (a result of sedentary 
behavior) in regards to health, the better informed such policies may be.   
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Appendix I: Tables 
 
Table 7: Number of observations for each state for all three years combined 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Hospital State Number of Observations Percentage of Observations 
GA 83,249 24.48% 
KY 45,931 13.51% 
NC 90,088 26.50% 
SC 32,162 9.46% 
TN 61,173 17.99% 
WV 27,400 8.06% 
Total 340,003 100% 
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